- Home
- Publications
- Publication Search
- Publication Details
Title
Management of patients with acute promyelocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 6, Pages 1277-1294
Publisher
Springer Nature
Online
2018-04-24
DOI
10.1038/s41375-018-0139-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631
- (2017) Matthew A. Kutny et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
- (2017) Uwe Platzbecker et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy
- (2017) D Martínez-Cuadrón et al. LEUKEMIA
- Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide
- (2017) S Kayser et al. LEUKEMIA
- First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid
- (2017) Ursula Creutzig et al. PEDIATRIC BLOOD & CANCER
- The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia
- (2016) H. Zhu et al. BLOOD
- Long-term outcome of acute promyelocytic leukemia treated with all- trans -retinoic acid, arsenic trioxide, and gemtuzumab
- (2016) Yasmin Abaza et al. BLOOD
- Autologous transplant remains the preferred therapy for relapsed APL in CR2
- (2016) C Ganzel et al. BONE MARROW TRANSPLANTATION
- Whatʼs new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
- (2016) Simon Mantha et al. CURRENT OPINION IN HEMATOLOGY
- Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting
- (2016) Michael Lishner et al. JOURNAL OF CLINICAL ONCOLOGY
- Severe acute axonal neuropathy following treatment with arsenic trioxide for acute promyelocytic leukemia: a case report
- (2016) Marcus Kuhn et al. Mediterranean Journal of Hematology and Infectious Diseases
- Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia
- (2015) Miguel A. Sanz et al. ANNALS OF HEMATOLOGY
- Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
- (2015) Thorsten Braun et al. CANCER
- Dose-adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure
- (2015) Frank Firkin et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
- (2015) Alan K Burnett et al. LANCET ONCOLOGY
- Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
- (2015) E Lengfelder et al. LEUKEMIA
- Acute promyelocytic leukemia: where did we start, where are we now and the future
- (2015) C C Coombs et al. Blood Cancer Journal
- Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia
- (2015) Sarah Perreault et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age
- (2014) Paola Finsinger et al. ANNALS OF HEMATOLOGY
- Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission
- (2014) Jennifer L. Holter Chakrabarty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia
- (2014) M. A. Sanz et al. BLOOD
- ACUTE PROMYELOCYTIC LEUKEMIA (APL): COMPARISON BETWEEN CHILDREN AND ADULTS
- (2014) Anna Maria Testi et al. Mediterranean Journal of Hematology and Infectious Diseases
- How I treat children and adolescents with acute promyelocytic leukaemia
- (2013) Oussama Abla et al. BRITISH JOURNAL OF HAEMATOLOGY
- Biology and management of therapy-related acute promyelocytic leukemia
- (2013) Francesco Lo-Coco et al. CURRENT OPINION IN ONCOLOGY
- Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia
- (2013) Yinjun Lou et al. HEMATOLOGICAL ONCOLOGY
- Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial
- (2013) Hong-Hu Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group
- (2012) Eva Lengfelder et al. ANNALS OF HEMATOLOGY
- All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
- (2012) H. J. Iland et al. BLOOD
- Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia
- (2012) Yingmei Zhang et al. CANCER
- Revisiting the differentiation paradigm in acute promyelocytic leukemia
- (2011) J. Ablain et al. BLOOD
- Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study
- (2011) W.-Y. Au et al. BLOOD
- AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
- (2011) G. Avvisati et al. BLOOD
- Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis
- (2011) Yoshiki Tsuchiya et al. Clinical and Experimental Nephrology
- Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy*
- (2011) Michelle A. Elliott et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effect of arsenic trioxide on the treatment of children with newly diagnosed acute promyelocytic leukemia in China
- (2011) Li Zhang et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
- (2011) Ardeshir Ghavamzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
- (2011) S Lehmann et al. LEUKEMIA
- HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
- (2011) Giuseppe Avvisati Mediterranean Journal of Hematology and Infectious Diseases
- Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
- (2010) M. A. Sanz et al. BLOOD
- Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
- (2010) B. L. Powell et al. BLOOD
- Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review
- (2010) T Kamimura et al. BONE MARROW TRANSPLANTATION
- Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses
- (2010) Ursula Creutzig et al. BRITISH JOURNAL OF HAEMATOLOGY
- Open issues on bleeding and thrombosis in acute promyelocytic leukemia
- (2010) Miguel A. Sanz et al. THROMBOSIS RESEARCH
- Arsenic Trioxide in a Hemodialytic Patient with Acute Promyelocytic Leukemia
- (2009) Yuko Yamamoto et al. ACTA HAEMATOLOGICA
- Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
- (2009) L. Ades et al. BLOOD
- Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia
- (2009) J. Zhou et al. BLOOD
- Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis
- (2009) P. Montesinos et al. HAEMATOLOGICA
- Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience
- (2009) Charikleia Kelaidi et al. JOURNAL OF CLINICAL ONCOLOGY
- High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG
- (2009) E Lengfelder et al. LEUKEMIA
- Treatment of Acute Promyelocytic Leukemia During Pregnancy
- (2009) Daisy Yang et al. PHARMACOTHERAPY
- Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
- (2008) P. Montesinos et al. BLOOD
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity
- (2008) L. H. Lindner et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
- (2008) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More